Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021

SELL
$6.23 - $10.03 $167,954 - $270,398
-26,959 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$8.81 - $16.96 $104,231 - $200,653
11,831 Added 78.21%
26,959 $250,000
Q4 2020

Feb 24, 2021

BUY
$8.5 - $12.85 $128,588 - $194,394
15,128 New
15,128 $134,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $494M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Emc Capital Management Portfolio

Follow Emc Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Emc Capital Management with notifications on news.